Previous
Pause
Next
Skip to Navigation
↓
Congresses
Year
Year
Year
-Year
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Researcher
- Any -
Afif
dyllanes
usuario_prueba
Almeida e Silva, Filomena Augusta
Angás Pajas, Jorge
Arenal , Raúl
Baptista , Pedro Miguel
Bernechea Navarro, María
Bover Arbós, Pere
Calvo Lacosta, Jorge Hugo
Carstensen , Hans-Heinrich
Cazcarro Castellano, Ignacio
Cobarrubias Baglietto, Sebastián Felipe
Espina Cadena, Laura
Fernandez Antoran, David
Gil Hernández, Vanesa
Gracia Lostao, Ana Isabel
Gurauskis , Jonas
Gómez Candón, David
Hernández Ainsa, Silvia
Hernández Latas, José Antonio
Hurtado Guerrero, Ramón
Jiménez Schuhmacher, Alberto
Juarez-Perez , Emilio J.
Köhler , Ralf
Lopes de Sousa Martins, Pedro Alexandre
Martín Yebra, Alba
Martínez Delgado, David
Millán Gasca, Javier
Montiel , Manuel
Muñoz Soro, José Félix
Olmo , Jose
Ordovás Vidal, Laura
Philippidis , George
Ramón García, Santiago
Roque , Carla
Schoorlemmer , Jon
Sola , Daniel
Stavridis , Stelios
Sánchez Martínez, Diego
Velasco Lozano, Susana
Íñiguez Dieste, David
Title
Title
Year
Models and control strategies in isothermal titration microcalorimetry with Peltier power compensation
1998
Forensic identification of deer and human DNA profiles in a case of furtive hunting.
1998
Kinetic studies of the binding mechanism of FMN to Anabæna apoflavodoxin
1998
ENDOR and HYSCORE characterization of flavoprotein semiquinones in relation to protein function
1998
A BICISTRONIC RECOMBINANT ADENOVIRUS CARRYING BOTH P53 AND P16 TUMOR SUPPRESSO GENES FOR TREATMENT OF P53-RESISTANT GLIOMAS.
1998
ANTITUMOR EFFECT OF ADENOVIRUS E1b DEFECTIVES IN UVEAL MELANOMAS.
1998
AN ANTITUMOR TREATMENT IN HUMAN CANCER WITH E1B GENE DEFECTIVE ADENOVIRUSES
1998
INFECTION WITH ADENOVIRUS E1B DEFECTIVES EXERTS A MARKED CYTOPATHIC EFFECT ON MICE CELLS DEFICIENT IN P16, P21, P27 OR P53 GENES
1998
SYNERGISTIC EFFECT OF p53, p53-p16 AND E2F-1 IN GLIOMAS SUGGEST DIFFERENT MECHANISM OF ACTIVATION OF APOPTOSIS.
1998
THE ADENOVIRUS E1a GENE IN CANCER GENE THERAPY.
1998
A NEW TOOL FOR GLIOMA TREATMENT: A MUTANT ADENOVIRUS THAT REPLICATES PREDOMINANTLY IN DIVIDING CELLS WITH ALTERED EXPRESSION OF Rb.
1998
TUMOR SUPPRESOR EFFECT OF THE ADENOVIRUS E1A GENE.
1998
E2F-DEPENDENT GLIOMA APOPTOSIS IN THE ABSENCE OF TRANSCRIPTIONAL ACTIVATION OF E2F-TARGET GENES
1998
THE ADENOVIRUS E1A GENE IN CANCER THERAPY
1998
A NOVEL THERAPEUTIC APPROACH FOR GLIOMAS: AN ADENOVIRUS DESIGN TO REPLICATE EXCLUSIVELY IN Rb-MUTANT CELLS.
1998
A NOVEL THERAPEUTIC APPROACH FOR GLIOMAS: AN ADENOVIRUS DESIGN TO REPLICATE EXCLUSIVELY IN Rb-MUTANT CELLS.
1998
Caracterización genética de la raza porcina Chato Murciano.
1998
El proyecto del Laboratorio del Amplificador de Energía: desarrollos y objetivos
1999
Thermodynamic characterization of tripeptide inhibitors of the HIV-1 protease
1999
Estudios neutrónicos y fluidodinámicos de fuentes intensas de neutrones de espalación
1999
Pages
« primera
‹ anterior
1
2
3
4
5
6
7
8
9
…
siguiente ›
última »